bradykinin, des-arg(9)- has been researched along with Dyspnea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Roche, JA; Roche, R | 1 |
1 other study(ies) available for bradykinin, des-arg(9)- and Dyspnea
Article | Year |
---|---|
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.
Topics: Angiotensin-Converting Enzyme 2; Betacoronavirus; Bradykinin; Bradykinin B2 Receptor Antagonists; Compassionate Use Trials; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dyspnea; Feedback, Physiological; Humans; Inflammation; Models, Biological; Off-Label Use; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Bradykinin; Receptors, Virus; SARS-CoV-2 | 2020 |